A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents.

Guo, Leilei; Qin, Xiaokang; Xue, Liting; Yang, Janine Y; Zhang, Yumei; Zhu, Shunwei; Ye, Gang; Tang, Renhong; Yang, WenQing

Guo, Leilei; Qin, Xiaokang; Xue, Liting; Yang, Janine Y; Zhang, Yumei; Zhu, Shunwei; Ye, Gang; Tang, Renhong; Yang, WenQing.

Afiliação

Guo L; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Pharmaceutical Co. Ltd, Nanjing, China.
Qin X; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Pharmaceutical Co. Ltd, Nanjing, China.
Xue L; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Pharmaceutical Co. Ltd, Nanjing, China.
Yang JY; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, United States.
Zhang Y; Department of Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Zhu S; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Pharmaceutical Co. Ltd, Nanjing, China.
Ye G; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Pharmaceutical Co. Ltd, Nanjing, China.
Tang R; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Pharmaceutical Co. Ltd, Nanjing, China.
Yang W; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Pharmaceutical Co. Ltd, Nanjing, China.